» Articles » PMID: 26016484

Trends in Telemedicine Use in Addiction Treatment

Overview
Publisher Biomed Central
Specialty Psychiatry
Date 2015 May 29
PMID 26016484
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Telemedicine use in addiction treatment and recovery services is limited. Yet, because it removes barriers of time and distance, telemedicine offers great potential for enhancing treatment and recovery for people with substance use disorders (SUDs). Telemedicine also offers clinicians ways to increase contact with SUD patients during and after treatment.

Case Description: A project conducted from February 2013 to June 2014 investigated the adoption of telemedicine services among purchasers of addiction treatment in five states and one county. The project assessed purchasers' interest in and perceived facilitators and barriers to implementing one or more of the following telemedicine modalities: telephone-based care, web-based screening, web-based treatment, videoconferencing, smartphone mobile applications (apps), and virtual worlds.

Discussion And Evaluation: Purchasers expressed the most interest in implementing videoconferencing and smartphone mobile devices. The anticipated facilitators for implementing a telemedicine app included funding available to pay for the telemedicine service, local examples of success, influential champions at the payer and treatment agencies, and meeting a pressing need. The greatest barriers identified were: costs associated with implementation, lack of reimbursement for telemedicine services, providers' unfamiliarity with technology, lack of implementation models, and confidentiality regulations. This paper discusses why the project participants selected or rejected different telemedicine modalities and the policy implications that purchasers and regulators of addiction treatment services should consider for expanding their use of telemedicine.

Conclusions: This analysis provides initial observations into how telemedicine is being implemented in addiction services in five states and one county. The project demonstrated that despite the considerable interest in telemedicine, implementation challenges exist. Future studies should broaden the sample analyzed and track technology implementation longitudinally to help the research and practitioner communities develop a greater understanding of technology implementation trends and practices.

Citing Articles

Patient perceptions of and experiences with stigma using telehealth for opioid use disorder treatment: a qualitative analysis.

Couch J, Whitcomb M, Buchheit B, Dorr D, Malinoski D, Korthuis P Harm Reduct J. 2024; 21(1):125.

PMID: 38937779 PMC: 11210005. DOI: 10.1186/s12954-024-01043-5.


A Comprehensive Literature Review of Digital Health Interventions in the Treatment of Substance Use Disorder With Special Focus on Mobile Applications.

Jordan H, Sahni S, Ahmed M, Fares J, Desai B, Lenchur C Cureus. 2023; 15(10):e47639.

PMID: 38021738 PMC: 10668628. DOI: 10.7759/cureus.47639.


Developing a Theoretically Informed Implementation Model for Telemedicine-Delivered Medication for Opioid Use Disorder: Qualitative Study With Key Informants.

Teck J, Gittins R, Zlatkute G, Oteo Perez A, Galea-Singer S, Baldacchino A JMIR Ment Health. 2023; 10:e47186.

PMID: 37851506 PMC: 10620637. DOI: 10.2196/47186.


The Efficacy of Telepsychiatry in Addiction Patients: A Systematic Review.

Kamma H, Alabbas M, Elashahab M, Abid N, Manaye S, Cheran K Cureus. 2023; 15(4):e38133.

PMID: 37252504 PMC: 10213379. DOI: 10.7759/cureus.38133.


Navigating the complexities of mobile medical app development from idea to launch, a guide for clinicians and biomedical researchers.

Mannino R, Arconada Alvarez S, Greenleaf M, Parsell M, Mwalija C, Lam W BMC Med. 2023; 21(1):109.

PMID: 36959646 PMC: 10035117. DOI: 10.1186/s12916-023-02833-7.


References
1.
Backhaus A, Agha Z, Maglione M, Repp A, Ross B, Zuest D . Videoconferencing psychotherapy: a systematic review. Psychol Serv. 2012; 9(2):111-131. DOI: 10.1037/a0027924. View

2.
Molfenter T, Capoccia V, Boyle M, Sherbeck C . The readiness of addiction treatment agencies for health care reform. Subst Abuse Treat Prev Policy. 2012; 7:16. PMC: 3439296. DOI: 10.1186/1747-597X-7-16. View

3.
Free C, Phillips G, Galli L, Watson L, Felix L, Edwards P . The effectiveness of mobile-health technology-based health behaviour change or disease management interventions for health care consumers: a systematic review. PLoS Med. 2013; 10(1):e1001362. PMC: 3548655. DOI: 10.1371/journal.pmed.1001362. View

4.
Hilty D, Ferrer D, Burke Parish M, Johnston B, Callahan E, Yellowlees P . The effectiveness of telemental health: a 2013 review. Telemed J E Health. 2013; 19(6):444-54. PMC: 3662387. DOI: 10.1089/tmj.2013.0075. View

5.
Chih M, Patton T, McTavish F, Isham A, Judkins-Fisher C, Atwood A . Predictive modeling of addiction lapses in a mobile health application. J Subst Abuse Treat. 2013; 46(1):29-35. PMC: 3963148. DOI: 10.1016/j.jsat.2013.08.004. View